Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.06
(+0.97%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Liabilities (Quarterly): 201.94M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 201.94M |
| June 30, 2024 | 191.41M |
| March 31, 2024 | 156.70M |
| December 31, 2023 | 190.26M |
| September 30, 2023 | 192.86M |
| June 30, 2023 | 197.74M |
| March 31, 2023 | 197.19M |
| December 31, 2022 | 215.48M |
| Date | Value |
|---|---|
| September 30, 2022 | 223.50M |
| June 30, 2022 | 234.94M |
| March 31, 2022 | 240.75M |
| December 31, 2021 | 67.41M |
| September 30, 2021 | 59.57M |
| June 30, 2021 | 55.88M |
| March 31, 2021 | 504.97M |
| December 31, 2020 | 504.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.88M
Minimum
Jun 2021
504.97M
Maximum
Mar 2021
214.72M
Average
197.46M
Median
Total Liabilities (Quarterly) Benchmarks
| Revance Therapeutics Inc | 624.59M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 726.50M |
| Shareholders Equity (Quarterly) | 524.56M |
| Debt to Equity Ratio | 0.0548 |
| Current Ratio | 4.355 |
| Net Debt Paydown Yield | -0.29% |